ANALYSIS PLAN. Continuous variables will be summarized using the number of observations, mean, standard deviation (SD), median, minimum, and maximum, as well as confidence intervals (CIs) or confidence limits where applicable. Categorical variables will be summarized with frequencies and percentages from each category. Any deviations to the analysis plan will be updated during the course of the study as part of a protocol amendment or will be detailed in the clinical study report.
ANALYSIS PLAN. Any deviations to the analysis plan will be updated during the course of the study as part of a protocol amendment or will be detailed in the clinical study report. All analyses will be conducted according to the applicable statistical analysis plan.
ANALYSIS PLAN. Data from a subset of subjects in the CLL949-C009 study will be combined with data from this study. This combined set will serve as the basis for all analyses detailed in this section. Subjects in CLL949-C009 will be included in the combined set only if they satisfy the following criterion: • BCVA of 20/20 or better in each eye at the Screening / Baseline / Dispense Visit
ANALYSIS PLAN. [Add a description of the end and time points and the planned statistical analyses including: The analysis set The analysis models (with factors and covariates) Any transformation of data Plans for handling of missing data Plans for addressing multiplicity issues; and Plans for sensitivity analyses.] APPENDIX 2: CLINICAL TRIALS [Specify the studies requested to access. Access can be granted to datasets from Novo Nordisk sponsored clinical trials completed after 2001 for product indications approved in both the EU and US, which Novo Nordisk assesses can be effectively de-identified to protect patient anonymity] PHASE ID CONDITION / TREATMENT
ANALYSIS PLAN. A thematic analysis approach was used in analyzing the qualitative data. The English translated data was analyzed through the categorization of respondents‟ opinions. The analysis was carried out in three stages suggested by Xxxxxxxx Xxxxx and Xxxxxxxx Xxxxxx (44):- first, the line-by-line coding of field notes and transcripts; second, the in-depth examination and interpretation of the resultant codes and their categorization into descriptive and analytical themes; and third, the development of an overarching theme. The coding involved the development of concepts, i.e. the data was splitted into discrete elements in order to expose underlying thoughts and meanings. The generated codes were further interpreted and categorized into descriptive codes. These latter codes were further distilled into abstract analytical themes around which results were presented. The researcher focused on a few key issues as analyzed to be themes. Quantitative data was analyzed by descriptive analysis using frequencies tables, percentages and graphs. This was used for two objectives; first is on the extent the government has deployed Human Resources for Health to Cardinal Rugambwa Mission Hospital and second is on the extent to which the government abides to financial commitment in terms of amount, time and frequency to Cardinal Rugambwa Mission Hospital as per SA.
ANALYSIS PLAN. By listing and specifying what types of analysis your project will likely require at the beginning of your project, you can ensure that your key models will include the relevant information, making the analysis easier and more efficient.
ANALYSIS PLAN. It is assumed that the analysis plans already developed will be used.
ANALYSIS PLAN. Descriptive Statistics Statistical analyses were conducted using the IBM Statistical Package for the Social Sciences (SPSS) Version 24. Descriptive statistics were conducted for all variables to examine the characteristics of the sample using mean and standard deviation for the continuous variables, and frequency and percentages for categorical variables.
ANALYSIS PLAN. Continuous variables will be summarized using the number of observations, mean, standard deviation (SD), median, minimum, and maximum, as well as confidence intervals (CIs) or
ANALYSIS PLAN. [Add a description of the end and time points and the planned statistical analyses including: The analysis set The analysis models (with factors and covariates) Any transformation of data Plans for handling of missing data Plans for addressing multiplicity issues; and Plans for sensitivity analyses.] APPENDIX 2: CLINICAL TRIALS [Specify the studies requested to access. Access can be granted to datasets from Novo Nordisk sponsored clinical trials completed after 2001 for product indications approved in both the EU and US, which Novo Nordisk assesses can be effectively de-identified to protect patient anonymity] PHASE ID CONDITION / TREATMENT [e.g. Phase 2] [e.g. NN1234-3333] [e.g. Metabolism and nutrition disorder Obesity] [e.g. Phase 2] [e.g. NN1234-3333] [e.g. Metabolism and nutrition disorder Obesity] [e.g. Phase 2] [e.g. NN1234-3333] [e.g. Metabolism and nutrition disorder Obesity] [e.g. Phase 2] [e.g. NN1234-3333] [e.g. Metabolism and nutrition disorder Obesity] [e.g. Phase 2] [e.g. NN1234-3333] [e.g. Metabolism and nutrition disorder Obesity] [e.g. Phase 2] [e.g. NN1234-3333] [e.g. Metabolism and nutrition disorder Obesity] APPENDIX 3: PUBLICATION PLAN
